JANSSEN PHARMACEUTICA supplier risk assessment Q1 2026 | Mexico pharmaceutical imports
JANSSEN PHARMACEUTICA imported 370 shipments in Q1 2026 across a single supplier and country. All imports originated from Mexico, representing 100% of the company's sourcing footprint. The dominant product category was HS Chapter 30 (pharmaceutical products), with HS code 300490 accounting for 269 shipments (73% of total volume). Top supplier JANSSEN-CILAG (Mexico) supplied all 370 shipments across three pharmaceutical product codes.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
JANSSEN PHARMACEUTICA recorded zero sanctions watchlist hits in Q1 2026. No suppliers in the import chain registered exposure to forced-labor indicators under UFLPA proximity criteria.
1 distinct tier-1 suppliers in Q1 2026
| JANSSEN-CILAG | Mexico | 370 |
Share of Q1 2026 inbound shipments by source country
2 tier-2 + 5 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.